JSM 2013 Home
Online Program Home
My Program

Keyword Search

Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Keyword Search Criteria: rare event returned 10 record(s)
Sunday, 08/04/2013
Statistical Methods Used in Safety Evaluation for NDA Submissions
Linyun Zhou, Takeda Global Research & Development
2:05 PM

A Second Source of Conservatism in Fisher's Exact Test for Rare Events
Mark Von Tress, Alcon Laboratories
2:35 PM

A Further Look Into Meta-Analysis of Rare Event Data for Drug Safety Assessment
Yujun Wu, Sanofi US; Hui Quan, Sanofi; Peng-liang Zhao, Sanofi US
3:35 PM

Monday, 08/05/2013
Risk Assessment for Rare Events Using Logistic Model Averaging
Chun-Shu Chen, National Changhua University of Education; Jin-Hua Chen, Graduate Institute of Biostatistics, China Medical University; Meng-Fan Huang, National Changhua University of Education


Assessing Drug Safety Using Bayesian Evidence Synthesis
David I. Ohlssen, Novartis Pharmaceuticals Corporation; Amy Xia, Amgen
2:30 PM

Tuesday, 08/06/2013
M&N, Wald, and Skellam: Who Excels in Rare-Event, Small-Sample, Interval Estimation of Risk Differences?
Oliver Bautista, Merck Sharp & Dohme Corp; Josh Chen, Merck; Ivan S. F. Chan, Merck Research Laboratories
8:55 AM

Predicting Rare Events in the Presence of Zero-Inflation and Covariate Misclassification: A Bayesian Approach
MaryAnn Morgan-Cox, Eli Lilly and Company; James D. Stamey, Baylor University; John W Seaman, Jr, Baylor University
9:50 AM

Wednesday, 08/07/2013
Case-Control Sampling for Brain Imaging and Enhancement Prediction
Gina-Maria Pomann, North Carolina State University; Russell Shinohara, Univ of Pennsylvania; Ana-Maria Staicu, North Carolina State University; Elizabeth Sweeney, Johns Hopkins University; Daniel Reich, National Institute of Neurological Disorders & Stroke
9:05 AM

Bayesian Inference for Meta-Analysis of 2X2 Contingency Tables
Yaqin Wang, AbbVie Inc.; Qi Tang, AbbVie Inc.; Natalia Kan-Dobrosky, AbbVie Inc.; Shihua Wen, Abbvie; Yuzhen Wang, AbbVie Inc.
11:20 AM

Inclusion of Zero-Event Trials Using Continuity Correction in Meta-Analyses of Rare Events
Tianyue Zhou, Sanofi
11:50 AM




2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.